Global Neuromodulation Devices and Implantable Infusion Pumps Market Research Report 2023(Status and Outlook)
Report Overview
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
Bosson Research’s latest report provides a deep insight into the global Neuromodulation Devices and Implantable Infusion Pumps market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neuromodulation Devices and Implantable Infusion Pumps Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neuromodulation Devices and Implantable Infusion Pumps market in any manner.
Global Neuromodulation Devices and Implantable Infusion Pumps Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Market Segmentation (by Type)
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Market Segmentation (by Application)
Parkinson's Disease
Epilepsy
Pain
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neuromodulation Devices and Implantable Infusion Pumps Market
Overview of the regional outlook of the Neuromodulation Devices and Implantable Infusion Pumps Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neuromodulation Devices and Implantable Infusion Pumps Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neuromodulation Devices and Implantable Infusion Pumps
1.2 Key Market Segments
1.2.1 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
1.2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET COMPETITIVE LANDSCAPE
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers (2018-2023)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturers (2018-2023)
3.3 Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Sales Sites, Area Served, Product Type
3.6 Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Situation and Trends
3.6.1 Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS INDUSTRY CHAIN ANALYSIS
4.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2018-2023)
6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Market Share by Type (2018-2023)
6.4 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2018-2023)
7 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Sales by Application (2018-2023)
7.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD) by Application (2018-2023)
7.4 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Application (2018-2023)
8 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET SEGMENTATION BY REGION
8.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
8.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
8.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region
8.2 North America
8.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Medtronic
9.1.1 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.1.4 Medtronic Business Overview
9.1.5 Medtronic Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
9.1.6 Medtronic Recent Developments
9.2 Boston Scientific Corporation
9.2.1 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.2.2 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.2.4 Boston Scientific Corporation Business Overview
9.2.5 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
9.2.6 Boston Scientific Corporation Recent Developments
9.3 St. Jude Medical
9.3.1 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.3.2 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.3.4 St. Jude Medical Business Overview
9.3.5 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
9.3.6 St. Jude Medical Recent Developments
9.4 Synapse Biomedical
9.4.1 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.4.2 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.4.4 Synapse Biomedical Business Overview
9.4.5 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
9.4.6 Synapse Biomedical Recent Developments
9.5 Nevro Corporation
9.5.1 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.5.2 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.5.4 Nevro Corporation Business Overview
9.5.5 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
9.5.6 Nevro Corporation Recent Developments
9.6 Neuropace
9.6.1 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.6.2 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.6.4 Neuropace Business Overview
9.6.5 Neuropace Recent Developments
9.7 Cyberonics
9.7.1 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.7.2 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.7.4 Cyberonics Business Overview
9.7.5 Cyberonics Recent Developments
9.8 Autonomic Technologies
9.8.1 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.8.2 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.8.4 Autonomic Technologies Business Overview
9.8.5 Autonomic Technologies Recent Developments
9.9 Avery Biomedical
9.9.1 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.9.2 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.9.4 Avery Biomedical Business Overview
9.9.5 Avery Biomedical Recent Developments
9.10 Greatbatch Medical
9.10.1 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.10.2 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.10.4 Greatbatch Medical Business Overview
9.10.5 Greatbatch Medical Recent Developments
10 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET FORECAST BY REGION
10.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast
10.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country
10.2.3 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region
10.2.4 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neuromodulation Devices and Implantable Infusion Pumps by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Neuromodulation Devices and Implantable Infusion Pumps by Type (2024-2029)
11.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Neuromodulation Devices and Implantable Infusion Pumps by Type (2024-2029)
11.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Application (2024-2029)
11.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Forecast by Application
11.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neuromodulation Devices and Implantable Infusion Pumps
1.2 Key Market Segments
1.2.1 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
1.2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET COMPETITIVE LANDSCAPE
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers (2018-2023)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturers (2018-2023)
3.3 Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Sales Sites, Area Served, Product Type
3.6 Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Situation and Trends
3.6.1 Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS INDUSTRY CHAIN ANALYSIS
4.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2018-2023)
6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Market Share by Type (2018-2023)
6.4 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2018-2023)
7 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Sales by Application (2018-2023)
7.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD) by Application (2018-2023)
7.4 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Application (2018-2023)
8 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET SEGMENTATION BY REGION
8.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
8.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
8.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region
8.2 North America
8.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Medtronic
9.1.1 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.1.4 Medtronic Business Overview
9.1.5 Medtronic Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
9.1.6 Medtronic Recent Developments
9.2 Boston Scientific Corporation
9.2.1 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.2.2 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.2.4 Boston Scientific Corporation Business Overview
9.2.5 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
9.2.6 Boston Scientific Corporation Recent Developments
9.3 St. Jude Medical
9.3.1 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.3.2 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.3.4 St. Jude Medical Business Overview
9.3.5 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
9.3.6 St. Jude Medical Recent Developments
9.4 Synapse Biomedical
9.4.1 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.4.2 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.4.4 Synapse Biomedical Business Overview
9.4.5 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
9.4.6 Synapse Biomedical Recent Developments
9.5 Nevro Corporation
9.5.1 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.5.2 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.5.4 Nevro Corporation Business Overview
9.5.5 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
9.5.6 Nevro Corporation Recent Developments
9.6 Neuropace
9.6.1 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.6.2 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.6.4 Neuropace Business Overview
9.6.5 Neuropace Recent Developments
9.7 Cyberonics
9.7.1 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.7.2 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.7.4 Cyberonics Business Overview
9.7.5 Cyberonics Recent Developments
9.8 Autonomic Technologies
9.8.1 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.8.2 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.8.4 Autonomic Technologies Business Overview
9.8.5 Autonomic Technologies Recent Developments
9.9 Avery Biomedical
9.9.1 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.9.2 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.9.4 Avery Biomedical Business Overview
9.9.5 Avery Biomedical Recent Developments
9.10 Greatbatch Medical
9.10.1 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
9.10.2 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
9.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Market Performance
9.10.4 Greatbatch Medical Business Overview
9.10.5 Greatbatch Medical Recent Developments
10 NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS MARKET FORECAST BY REGION
10.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast
10.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country
10.2.3 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region
10.2.4 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neuromodulation Devices and Implantable Infusion Pumps by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Neuromodulation Devices and Implantable Infusion Pumps by Type (2024-2029)
11.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Neuromodulation Devices and Implantable Infusion Pumps by Type (2024-2029)
11.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Application (2024-2029)
11.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Forecast by Application
11.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neuromodulation Devices and Implantable Infusion Pumps Market Size Comparison by Region (M USD)
Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Manufacturers (2018-2023)
Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2022)
Table 10. Global Market Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Sales Sites and Area Served
Table 12. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neuromodulation Devices and Implantable Infusion Pumps
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
Table 22. Market Restraints
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (K Units)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type (M USD)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2018-2023)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2018-2023)
Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD) by Type (2018-2023)
Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Share by Type (2018-2023)
Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2018-2023)
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2023) & (K Units)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2018-2023)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2023) & (M USD)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application (2018-2023)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Application (2018-2023)
Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2023) & (K Units)
Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2018-2023)
Table 39. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023) & (K Units)
Table 40. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023) & (K Units)
Table 41. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2023) & (K Units)
Table 42. South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023) & (K Units)
Table 43. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2023) & (K Units)
Table 44. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 45. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 46. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 47. Medtronic Business Overview
Table 48. Medtronic Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
Table 49. Medtronic Recent Developments
Table 50. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 51. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 52. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 53. Boston Scientific Corporation Business Overview
Table 54. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
Table 55. Boston Scientific Corporation Recent Developments
Table 56. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 57. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 58. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. St. Jude Medical Business Overview
Table 60. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
Table 61. St. Jude Medical Recent Developments
Table 62. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 63. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 64. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 65. Synapse Biomedical Business Overview
Table 66. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
Table 67. Synapse Biomedical Recent Developments
Table 68. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 69. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 70. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 71. Nevro Corporation Business Overview
Table 72. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
Table 73. Nevro Corporation Recent Developments
Table 74. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 75. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 76. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Neuropace Business Overview
Table 78. Neuropace Recent Developments
Table 79. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 80. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 81. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Cyberonics Business Overview
Table 83. Cyberonics Recent Developments
Table 84. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 85. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 86. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Autonomic Technologies Business Overview
Table 88. Autonomic Technologies Recent Developments
Table 89. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 90. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 91. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Avery Biomedical Business Overview
Table 93. Avery Biomedical Recent Developments
Table 94. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 95. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 96. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Greatbatch Medical Business Overview
Table 98. Greatbatch Medical Recent Developments
Table 99. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2024-2029) & (K Units)
Table 100. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region (2024-2029) & (M USD)
Table 101. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2024-2029) & (K Units)
Table 102. North America Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2024-2029) & (M USD)
Table 103. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2024-2029) & (K Units)
Table 104. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2024-2029) & (M USD)
Table 105. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2024-2029) & (K Units)
Table 106. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region (2024-2029) & (M USD)
Table 107. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2024-2029) & (K Units)
Table 108. South America Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2024-2029) & (M USD)
Table 109. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Country (2024-2029) & (Units)
Table 110. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2024-2029) & (M USD)
Table 111. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2024-2029) & (K Units)
Table 112. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Type (2024-2029) & (M USD)
Table 113. Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Type (2024-2029) & (USD/Unit)
Table 114. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Forecast by Application (2024-2029)
Table 115. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Application (2024-2029) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neuromodulation Devices and Implantable Infusion Pumps Market Size Comparison by Region (M USD)
Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Manufacturers (2018-2023)
Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2022)
Table 10. Global Market Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Sales Sites and Area Served
Table 12. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neuromodulation Devices and Implantable Infusion Pumps
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
Table 22. Market Restraints
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (K Units)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type (M USD)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2018-2023)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2018-2023)
Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD) by Type (2018-2023)
Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Share by Type (2018-2023)
Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2018-2023)
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2023) & (K Units)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2018-2023)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2023) & (M USD)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application (2018-2023)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Application (2018-2023)
Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2023) & (K Units)
Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2018-2023)
Table 39. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023) & (K Units)
Table 40. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023) & (K Units)
Table 41. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2023) & (K Units)
Table 42. South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023) & (K Units)
Table 43. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2023) & (K Units)
Table 44. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 45. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 46. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 47. Medtronic Business Overview
Table 48. Medtronic Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
Table 49. Medtronic Recent Developments
Table 50. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 51. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 52. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 53. Boston Scientific Corporation Business Overview
Table 54. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
Table 55. Boston Scientific Corporation Recent Developments
Table 56. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 57. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 58. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. St. Jude Medical Business Overview
Table 60. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
Table 61. St. Jude Medical Recent Developments
Table 62. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 63. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 64. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 65. Synapse Biomedical Business Overview
Table 66. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
Table 67. Synapse Biomedical Recent Developments
Table 68. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 69. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 70. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 71. Nevro Corporation Business Overview
Table 72. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps SWOT Analysis
Table 73. Nevro Corporation Recent Developments
Table 74. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 75. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 76. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Neuropace Business Overview
Table 78. Neuropace Recent Developments
Table 79. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 80. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 81. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Cyberonics Business Overview
Table 83. Cyberonics Recent Developments
Table 84. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 85. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 86. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Autonomic Technologies Business Overview
Table 88. Autonomic Technologies Recent Developments
Table 89. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 90. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 91. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Avery Biomedical Business Overview
Table 93. Avery Biomedical Recent Developments
Table 94. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Basic Information
Table 95. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Overview
Table 96. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Greatbatch Medical Business Overview
Table 98. Greatbatch Medical Recent Developments
Table 99. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2024-2029) & (K Units)
Table 100. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region (2024-2029) & (M USD)
Table 101. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2024-2029) & (K Units)
Table 102. North America Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2024-2029) & (M USD)
Table 103. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2024-2029) & (K Units)
Table 104. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2024-2029) & (M USD)
Table 105. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2024-2029) & (K Units)
Table 106. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region (2024-2029) & (M USD)
Table 107. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2024-2029) & (K Units)
Table 108. South America Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2024-2029) & (M USD)
Table 109. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Country (2024-2029) & (Units)
Table 110. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Country (2024-2029) & (M USD)
Table 111. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2024-2029) & (K Units)
Table 112. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Type (2024-2029) & (M USD)
Table 113. Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Type (2024-2029) & (USD/Unit)
Table 114. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Forecast by Application (2024-2029)
Table 115. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Application (2024-2029) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD), 2018-2029
Figure 5. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD) (2018-2029)
Figure 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (M USD)
Figure 11. Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Manufacturers in 2022
Figure 12. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers in 2022
Figure 13. Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neuromodulation Devices and Implantable Infusion Pumps Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Type
Figure 18. Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type (2018-2023)
Figure 19. Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type in 2022
Figure 20. Market Size Share of Neuromodulation Devices and Implantable Infusion Pumps by Type (2018-2023)
Figure 21. Market Size Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2018-2023)
Figure 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2022
Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application (2018-2023)
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application in 2022
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Application (2018-2023)
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2018-2023)
Figure 30. North America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 31. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2022
Figure 32. U.S. Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 33. Canada Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) and Growth Rate (2018-2023)
Figure 34. Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 36. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2022
Figure 37. Germany Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 38. France Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 39. U.K. Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 40. Italy Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 41. Russia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 42. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2022
Figure 44. China Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 45. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 46. South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 47. India Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 48. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 49. South America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (K Units)
Figure 50. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2022
Figure 51. Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 52. Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 53. Columbia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 54. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 57. UAE Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 58. Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 59. Nigeria Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 60. South Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 61. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Volume (2018-2029) & (K Units)
Figure 62. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Type (2024-2029)
Figure 65. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2024-2029)
Figure 66. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Application (2024-2029)
Figure 1. Product Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD), 2018-2029
Figure 5. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (M USD) (2018-2029)
Figure 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country (M USD)
Figure 11. Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Manufacturers in 2022
Figure 12. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers in 2022
Figure 13. Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neuromodulation Devices and Implantable Infusion Pumps Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Type
Figure 18. Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type (2018-2023)
Figure 19. Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type in 2022
Figure 20. Market Size Share of Neuromodulation Devices and Implantable Infusion Pumps by Type (2018-2023)
Figure 21. Market Size Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2018-2023)
Figure 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2022
Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application (2018-2023)
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application in 2022
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate by Application (2018-2023)
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2018-2023)
Figure 30. North America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 31. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2022
Figure 32. U.S. Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 33. Canada Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) and Growth Rate (2018-2023)
Figure 34. Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 36. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2022
Figure 37. Germany Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 38. France Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 39. U.K. Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 40. Italy Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 41. Russia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 42. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2022
Figure 44. China Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 45. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 46. South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 47. India Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 48. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 49. South America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (K Units)
Figure 50. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2022
Figure 51. Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 52. Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 53. Columbia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 54. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 57. UAE Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 58. Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 59. Nigeria Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 60. South Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2018-2023) & (K Units)
Figure 61. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Volume (2018-2029) & (K Units)
Figure 62. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Type (2024-2029)
Figure 65. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2024-2029)
Figure 66. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Application (2024-2029)
